Literature DB >> 14278890

MYOSARCOMA OF THE UTERUS; A CLINICOPATHOLOGICAL STUDY.

R H SPIRO, L G KOSS.   

Abstract

Keywords:  DIAGNOSIS, DIFFERENTIAL; GERIATRICS; HYSTERECTOMY; LEIOMYOMA; MORTALITY; MYOSARCOMA; NEOPLASM RADIOTHERAPY; NEOPLASM STATISTICS; NEOPLASMS, RADIATION-INDUCED; PATHOLOGY; PROGNOSIS; UTERINE NEOPLASMS

Mesh：

Year:  1965        PMID： 14278890     DOI： 10.1002/1097-0142(196505)18:5<571::aid-cncr2820180506>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

1.  Leiomyosarcomatosis of probable uterine origin with long survival--a case report.

Authors:  R A Young
Journal:  Postgrad Med J       Date:  1977-05       Impact factor: 2.401

2.  Leiomyoma of the uterus with bilateral pulmonary metastases.

Authors:  R Lefebvre; T Nawar; R Fortin; J Genest
Journal:  Can Med Assoc J       Date:  1971-09-04       Impact factor: 8.262

3.  Methotrexate in treatment of sarcomata.

Authors:  E Wiltshaw
Journal:  Br Med J       Date:  1967-04-15

4.  Nucleolar organizer regions in uterine sarcomas.

Authors:  L L Boquist
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

5.  Primary leiomyosarcoma of the spine.

Authors:  T H Lo; W J van Rooij; J L Teepen; I T Verhagen
Journal:  Neuroradiology       Date:  1995-08       Impact factor: 2.804

Review 6.  Leiomyosarcoma in bone: primary or secondary? A case report and review of the literature.

Authors:  V L Fornasier; D Paley
Journal:  Skeletal Radiol       Date:  1983       Impact factor: 2.199

7.  Combined modality management of local and disseminated adult soft tissue sarcomas: a review of 257 cases seen over 10 years at the Christie Hospital & Holt Radium Institute, Manchester.

Authors:  V H Bramwell; D Crowther; D P Deakin; R Swindell; M Harris
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

8.  Squamous carcinoma of the body of the uterus.

Authors:  I D Hopkin; R A Harlow; P J Stevens
Journal:  Br J Cancer       Date:  1970-03       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.